Skip to main content
. 2017 Jul 24;6(7):e363. doi: 10.1038/oncsis.2017.63

Figure 7.

Figure 7

ZNF687 targets the BMI1, NANOG and OCT4 promoters. (a) ChIP analysis of the physical association of regions of the target gene promoters with ZNF687. ChIP assays were performed using a FLAG antibody to identify ZNF687-binding sites in the target gene promoters. IgG, negative control. (b) Luciferase reporter gene assays of the target gene promoters. Renilla luciferase activity, normalized control. (c) Western blot analysis of BMI1, NANOG and OCT4 protein expression in Huh7 and Hep3B cells stably overexpressing ZNF687 or in which ZNF687 had been silenced. α-Tubulin, loading control. (d) Quantification of tumorspheres formed in ZNF687-overexpressing cells treated with BMI1, NANOG or OCT4 small interfering RNA (siRNA). (e) Hoechst 33342 dye exclusion was used to examine the effects of BMI1, NANOG or OCT4 knockdown on the proportion of SP+ cells in ZNF687-overexpressing cells. Bars, mean±s.d. of three independent experiments. *P<0.05.